PRODUCT LABELING, PRODUCT LITERATURE Sample Clauses

PRODUCT LABELING, PRODUCT LITERATURE. 8.1 The Products shall be labeled as mutually agreed between the Parties upon completion of the activities described in the Development Agreement, and advertised under Stryker’s name, provided that the statement “Manufactured by Conformis”, or variations thereof acceptable to Stryker shall appear on any printed material related thereto if and to the extent required by Applicable Laws. Supplier shall provide Stryker reasonable inputs to formulate instructions for use (“IFU”) to be included with its applicable Triathlon product, to the extent such IFU addresses the applicable Product. With respect to the Products, Supplier shall be responsible for submitting to the FDA’s Global Unique Device Identifier Database (GUDID), maintaining submissions and ensuring that the device and package label bears the UDI through application of Global GS1 standards. Otherwise with respect to Stryker’s Triathlon product, Stryker shall be responsible for submitting to the FDA’s Global Unique Device Identifier Database (GUDID), maintaining submissions and ensuring that the device and package label bears the UDI through application of Global GS1 standards, subject to Supplier’s provision of reasonable information and assistance with respect to the Products.
AutoNDA by SimpleDocs
PRODUCT LABELING, PRODUCT LITERATURE. Final Product image, brand use, positioning and packaging manufactured by Rohto will be subject to OMP’s prior written approval on an annual basis, which approval shall not be unreasonably withheld. To the extent that Rohto materially alters any Product packaging, and/or reintroduces new or upgraded Products that are based on the Products approved by OMP hereunder, all such changes also will be subject to OMP’s prior written approval, which approval also shall not be unreasonably withheld. The package label for Products sold by Rohto pursuant to this Agreement shall, to the extent permitted by Applicable Law, reflect OMP’s Product Patents or variations thereof acceptable to OMP. All printed material related thereto shall be agreeable to both Parties and acceptable under Applicable Law.
PRODUCT LABELING, PRODUCT LITERATURE. The package label for Product manufactured by Alfacell and sold to Distributor pursuant to this Agreement shall, to the extent permitted by Applicable Law, reflect Alfacell’s trademark and patent rights or variations thereof acceptable to Alfacell. All other printed material related thereto shall be agreeable to both Parties and acceptable under Applicable Law. Distributor shall promote and sell Product throughout the Territory under Alfacell’s Product trade name ONCONASE®, or such other trade name determined by Alfacell, which is and shall be owned and controlled by Alfacell, or such other Product trade name as Alfacell shall designate. Alfacell shall also determine the trademark to accompany the trade name it selects for the Product. The size of the trademarks for the Product and all Product labeling shall be in a form acceptable to Alfacell and in compliance with all Applicable Law, provided that, all packaging design, labels, trade names, trademarks and copyrights used for the Product shall be owned by Alfacell. Distributor shall not alter or remove any trademarks, labels or packaging applied to Product. Except only as permitted in connection with its promotion and sale of Product as permitted in this Agreement, nothing contained in this Agreement shall grant to Distributor any right, title or interest in Alfacell’s trademarks, trade names, copyrights or other intellectual property rights. At no time during or after the term of this Agreement shall Distributor or its Affiliates challenge or assist others to challenge Alfacell’s trademarks, trade names, copyrights or the registration thereof, or use or register, or attempt to use or register, any trademarks or trade names confusingly similar to those of Alfacell. In connection with its marketing efforts hereunder, all representations of Alfacell’s trademarks that Distributor intends to use shall first be submitted to Alfacell for approval of size, design, color, and other details, which shall not be unreasonably withheld, or shall be exact copies of those used by Alfacell. If any of Alfacell’s trademarks are to be used in conjunction with another trademark on or in relation to Product, then Alfacell’s mxxx shall be presented of equal or greater size than the other with equal or greater prominence than the other, but nevertheless separated from the other so that each appears to be a mxxx in its own right, distinct from the other mxxx. 5. PAYMENT FROM DISTRIBUTOR

Related to PRODUCT LABELING, PRODUCT LITERATURE

  • Product The term “

  • Marketing Materials (a) During the term of this Agreement, the Sub-Adviser agrees to furnish the Manager at its principal office for prior review and approval by the Manager all written and/or printed materials, including but not limited to, PowerPointÒ or slide presentations, news releases, advertisements, brochures, fact sheets and other promotional, informational or marketing materials (the “Marketing Materials”) for internal use or public dissemination, that are produced or are for use or reference by the Sub-Adviser, its affiliates or other designees, broker-dealers or the public in connection with the Series, and Sub-Adviser shall not use any such materials if the Manager reasonably objects in writing within five business days (or such other period as may be mutually agreed) after receipt thereof. Marketing Materials may be furnished to the Manager by first class or overnight mail, facsimile transmission equipment, electronic delivery or hand delivery.

  • Promotional Materials In the event that the Fund or the Adviser makes available any promotional materials related to the Securities or the transactions contemplated hereby intended for use only by registered broker-dealers and registered representatives thereof by means of an Internet web site or similar electronic means, the Adviser will install and maintain, or will cause to be installed and maintained, pre-qualification and password-protection or similar procedures which are reasonably designed to effectively prohibit access to such promotional materials by persons other than registered broker-dealers and registered representatives thereof.

  • Labeling Upon request, Lessee will xxxx the Equipment indicating Lessor's interest with labels provided by Lessor. Lessee will keep all Equipment free from any other marking or labeling which might be interpreted as a claim of ownership.

  • Promotional Material In the event that the Fund or the Investment Adviser makes available any promotional materials related to the Securities or the transactions contemplated hereby intended for use only by registered broker-dealers and registered representatives thereof by means of an Internet web site or similar electronic means, the Investment Adviser will install and maintain or will cause to be installed and maintained, pre-qualification and password-protection or similar procedures which are reasonably designed to effectively prohibit access to such promotional materials by persons other than registered broker-dealers and registered representatives thereof.

  • API A. Reliant shall supply to Cardinal Health for Manufacturing and Packaging, at Reliant’s sole cost, the API and applicable reference standards in quantities sufficient to meet Reliant’s requirements for each Product as further set forth in Article 4. Prior to delivery of any of the API or reference standard to Cardinal Health for Manufacturing and Packaging, Reliant shall provide to Cardinal Health a copy of the API Material Safety Data Sheet (“MSDS”), as amended, and any subsequent revisions thereto. Reliant shall supply the API, reference standards, and Certificate of Analysis FOB the Facility no later than thirty (30) days before the scheduled Manufacture Date upon which such API will be used by Cardinal Health. Upon receipt of the API, Cardinal Health shall conduct identification testing of the API. Cardinal Health shall use the API solely and exclusively for Manufacturing and Packaging under this Agreement. The maximum volume of API that Reliant supplies to Cardinal Health shall not exceed the amount reflected in the Firm Commitment and the next six (6) months of the Rolling Forecast.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Product Trademarks BMS shall be solely responsible for the selection (including the creation, searching and clearing), registration, maintenance, policing and enforcement of all trademarks developed for use in connection with the marketing, sale or distribution of Products in the Field in the Territory (the “Product Marks”). BMS shall own all Product Marks, and all trademark registrations for said marks.

  • Product Specifications The Company agrees that all Products sold to Xxxx hereunder shall conform to the respective specifications set forth on Schedule A or to such other specifications as are from time to time agreed upon by the Parties.

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

Time is Money Join Law Insider Premium to draft better contracts faster.